These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 16711505

  • 1. [Activated recombinant factor VII for bleeding after a kidney transplant: reflections].
    Pajares A, Larrea L.
    Rev Esp Anestesiol Reanim; 2006 Apr; 53(4):266-7; author reply 268. PubMed ID: 16711505
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia].
    Gielen-Wijffels SE, van Mook WN, Ramsay G.
    Ned Tijdschr Geneeskd; 2003 Mar 01; 147(9):419. PubMed ID: 12661464
    [No Abstract] [Full Text] [Related]

  • 3. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery.
    Daniloś J, Goral A, Paluszkiewicz P, Przesmycki K, Kotarski J.
    Obstet Gynecol; 2003 Jun 01; 101(6):1172-3. PubMed ID: 12798520
    [Abstract] [Full Text] [Related]

  • 4. Recombinant activated factor VII in the management of massive obstetric bleeding.
    Palomino MA, Chaparro MJ, de Elvira MJ, Curiel EB.
    Blood Coagul Fibrinolysis; 2006 Apr 01; 17(3):226-7. PubMed ID: 16575264
    [No Abstract] [Full Text] [Related]

  • 5. The use of recombinant-activated factor VII to successfully control postoperative critical bleeding after emergency repair of ruptured abdominal aortic aneurysm in a noncoagulopathic patient.
    Dell'Utri D, Passariello M.
    J Cardiothorac Vasc Anesth; 2006 Aug 01; 20(4):570-2. PubMed ID: 16884992
    [No Abstract] [Full Text] [Related]

  • 6. Caution with the use of recombinant activated factor VII in treating postoperative hemorrhage in cardiac surgery.
    Al-Ruzzeh S, Mahmoud A, Shah S, O'Regan D.
    Ann Thorac Surg; 2007 Jan 01; 83(1):355; author reply 355-6. PubMed ID: 17184710
    [No Abstract] [Full Text] [Related]

  • 7. Thromboelastometry to guide recombinant activated factor VII therapy for postoperative refractory intracranial bleeding.
    Hirasaki Y, Suematsu Y, Yasuda T, Tajima K.
    Anesth Analg; 2010 Jan 01; 110(1):261-2. PubMed ID: 20023190
    [No Abstract] [Full Text] [Related]

  • 8. [Application of recombinant activated factor VII in gynecological intervention (case report)].
    Nacheva A, Gateva Zh, Atanasova V.
    Akush Ginekol (Sofiia); 2004 Jan 01; 43 Suppl 4():3-5. PubMed ID: 15673003
    [No Abstract] [Full Text] [Related]

  • 9. Successful control of severe postoperative bleeding with recombinant factor VIIa in a case of refractory idiopathic thrombocytopenic purpura.
    Aguilar C, Lucía JF.
    Am J Hematol; 2007 Mar 01; 82(3):246-7. PubMed ID: 16924645
    [No Abstract] [Full Text] [Related]

  • 10. Recombinant activated factor VII for intractable bleeding post splenectomy in a patient with myeloproliferative disorder.
    El Kinge AR, Mahfouz RA, Shamseddine AI, Taher AT.
    Blood Coagul Fibrinolysis; 2007 Sep 01; 18(6):577-9. PubMed ID: 17762536
    [Abstract] [Full Text] [Related]

  • 11. Recombinant activated factor VII in cardiac surgery--will we ever know for sure?
    Silver DA, D'Ambra MN.
    Crit Care Med; 2007 Jul 01; 35(7):1782-3. PubMed ID: 17581365
    [No Abstract] [Full Text] [Related]

  • 12. Failure of recombinant FVIIa as treatment for abdominal bleeding in acquired hemophilia.
    Makris M, Hampton KK, Preston EE.
    Am J Hematol; 2001 Jan 01; 66(1):67-8. PubMed ID: 11426500
    [No Abstract] [Full Text] [Related]

  • 13. [Activated recombinant factor VII for bleeding after a kidney transplant].
    Vidal MA, Sebastianes C, Eizaga R, Martínez E, Torres LM.
    Rev Esp Anestesiol Reanim; 2005 Dec 01; 52(10):638-9. PubMed ID: 16435622
    [No Abstract] [Full Text] [Related]

  • 14. Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
    Jirapinyo M, Manonai J, Herabutya Y, Chuncharunee S.
    J Med Assoc Thai; 2007 May 01; 90(5):977-81. PubMed ID: 17596055
    [Abstract] [Full Text] [Related]

  • 15. Recombinant factor VIIa reduces bleeding risk in patients on platelet aggregation inhibitors immediately prior to renal transplantation--a retrospective analysis.
    Loertzer H, Soukup J, Fornara P.
    Urol Int; 2007 May 01; 78(2):135-9. PubMed ID: 17293653
    [Abstract] [Full Text] [Related]

  • 16. Management of severe sphincterotomy bleeding with recombinant activated factor VII.
    Garrido-Serrano A.
    Gastrointest Endosc; 2012 Oct 01; 76(4):925-6. PubMed ID: 22985655
    [No Abstract] [Full Text] [Related]

  • 17. Use of recombinant activated factor VII (rFVIIa-NovoSeven) in the treatment of uncontrolled postsurgical hemorrhage in a patient with deep venous thrombosis and caval filter. A case report.
    Marson F, Farnia A, Callegher L, Casagrande L, Surdu M, Sarpellon M.
    Minerva Anestesiol; 2006 Oct 01; 72(7-8):675-82. PubMed ID: 16865086
    [Abstract] [Full Text] [Related]

  • 18. Successful treatment of severe bleeding with recombinant factor VIIa after kidney transplantation.
    Gielen-Wijffels SE, van Mook WN, van der Geest S, Ramsay G.
    Intensive Care Med; 2004 Jun 01; 30(6):1232-4. PubMed ID: 14985956
    [Abstract] [Full Text] [Related]

  • 19. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
    Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, Cameron P.
    Ann Thorac Surg; 2008 Mar 01; 85(3):836-44. PubMed ID: 18291152
    [Abstract] [Full Text] [Related]

  • 20. Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation.
    Verrijckt A, Proulx F, Morneau S, Vobecky S.
    J Thorac Cardiovasc Surg; 2004 Jun 01; 127(6):1812-3. PubMed ID: 15173742
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.